Lieff Cabraser Civil Justice Blog
$225 Million Settlement Announced in Cipro Antitrust Litigation

$225 Million Settlement Announced in Cipro Antitrust Litigation

Lieff Cabraser, Zwerling, Schachter & Zwerling, LLP, and the Joseph Saveri Law Firm represent California consumers and third party payors in a class action lawsuit charging that Bayer Corporation, Barr Laboratories, and the HMR Defendants colluded to block consumer access to affordable, generic versions of Cipro through a massive $398.1 million payment by Bayer to Barr and other generic drug makers.

On January 25, 2017, Plaintiffs filed a Motion for Preliminary Approval of a proposed $225 million settlement with Barr Laboratories. The Court previously approved settlements with Bayer and the HMR defendants, which total $174 million. If the Court approves the $225 million settlement with Barr, the Class’s total recovery will be $399 million. The amount exceeds the payment Bayer made to Barr and to the HMR defendants not to compete, and is approximately $68 million more than Plaintiffs’ damage estimate. It is an extraordinary result for the Class.